Liposomes as drug delivery systems for the treatment of TB.
about
Combating Tuberculosis Infection: A Forbidding ChallengeSynthetic Nanoparticles for Vaccines and ImmunotherapyIsoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.Lyophilization of a triply unsaturated phospholipid: effects of trace metal contaminantsLiposomes and their applications in molecular imaging.Natural carriers for application in tuberculosis treatment.Nanoliposome-based antibacterial drug delivery.The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.Nitric oxide in paediatric respiratory disorders: novel interventions to address associated vascular phenomena?Composition influence on pulmonary delivery of rifampicin liposomesGelatinized-core liposomes: Toward a more robust carrier for hydrophilic molecules.Formulation of 99mTechnetium-labeled leuprolide loaded liposomes and its biodistribution study in New Zealand white female rabbits for assessment of its uterine targeting efficiency.Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies
P2860
Q26750683-D1895D50-6351-469B-9623-4F8F10221715Q28085375-D1362D34-C259-4A2C-B2F2-DA8AC5E8D35BQ34910919-713D96EE-5F6B-4D67-BCAC-C01AC9941E9BQ35125060-EA6C2B1F-2E88-45A7-8EC8-DD9945F28E37Q35950533-6BAF2945-F4BA-41B3-8AD3-0957226202C1Q37158892-AC82ECC9-2ABE-47C2-AB43-327187A9A4ADQ37231006-B8B8C052-791A-463A-A66C-D904ACA865D7Q38007179-1AA99B2D-8C3E-4ADF-ADAE-EA13618CA83AQ38044741-25BF9C75-4C26-4E0D-98EE-3BF12C76DFF7Q38169247-ADA69CFF-B6DB-47B8-A0F6-921994FB99D1Q38247429-F2D3FDD9-22CB-4903-A255-C1DDF73307A7Q38825691-A4FDC3D0-DAB6-46A6-A6DA-F2BC55A405DAQ38842183-1160EDF4-5563-4C0B-A41D-55152864BB94Q42087785-C73A1F8C-8095-47B5-BF12-54C336CA08DCQ45946391-C1752CE1-5FAE-4C6E-B4C7-E871719E0121Q47596256-F5D56B3B-2E66-4413-B0EC-B187F489FB8EQ48606369-9F9B7947-47D7-4053-9F16-6AD1BE2560FDQ57172145-7FA5C85D-A901-4B6F-8585-EA218F021D0D
P2860
Liposomes as drug delivery systems for the treatment of TB.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Liposomes as drug delivery systems for the treatment of TB.
@en
Liposomes as drug delivery systems for the treatment of TB.
@nl
type
label
Liposomes as drug delivery systems for the treatment of TB.
@en
Liposomes as drug delivery systems for the treatment of TB.
@nl
prefLabel
Liposomes as drug delivery systems for the treatment of TB.
@en
Liposomes as drug delivery systems for the treatment of TB.
@nl
P2093
P2860
P356
P1433
P1476
Liposomes as drug delivery systems for the treatment of TB.
@en
P2093
José L F C Lima
Marina Pinheiro
Marlene Lúcio
Salette Reis
P2860
P304
P356
10.2217/NNM.11.122
P577
2011-10-01T00:00:00Z